select trial semaglutide nejm Phase 3 of in Metabolic Dysfunction–Associated Steatohepatitis NEJM: Once-Weekly Semaglutide in Adults

While Ozempic focuses on type 2 diabetes management, Wegovy is tailored for long-term weight control

As soon as this changes, we will keep you updated

@AmDiabetesAssn @ADA_DiabetesPro And the summary of the P2 trial for retatrutide in PPL with #obesity #ADA2023 @AmDiabetesAssn @ADA_Pubs #weightloss

doi: 10.1001/jamapediatrics.2013.4200

In addition to these common side effects, there are some less common but more serious potential side effects, such as inflammation of the pancreas, gallbladder disease, kidney injury, and blockage of the intestines

Their expertise and guidance are crucial in educating patients about the potential side effects of semaglutide, including dizziness, and in developing personalized management plans